Characterisation of Notch asparaginyl hydroxylation by FIH-1.
Characterisation of Notch asparaginyl hydroxylation by FIH-1.
批准号:
nhmrc : 453681
负责人:
A/Pr Daniel Peet
金额:
$20.53万
依托单位国家:
澳大利亚
项目类别:
NHMRC Project Grants
财政年份:
2007
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2007-01-01 至 2009-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cells within our body receive numerous signals telling them when to grow, when to turn into another cell type and exactly what type, and even how to respond to situations like low oxygen. These signals and cells response are very important during embryonic development, when these signals cause a single cell to become a complete person, and also in adults. Here in the embryo, and also in adults, stem cells are very important because they can become many different kinds of cells, depending on what the body needs. When the signals don't work properly, they cause major problems and diseases, from birth defects, to cancer. Notch is an important protein involved in receiving and passing on certain signals, and is found in organisms as diverse as worms and humans. It tells cells, especially stem cells and other similar cells, when and how to change from one type of cell to another. For example, it is very important in the generation of many different types of blood cells from a single precursor cell. Notch has also been implicated in human diseases such as cancer, where signalling goes wrong and cells keep multiplying out of control, and also certain types of heart disease. Another protein, called FIH, is an oxygen sensor that signals to the cell when there is not enough oxygen around. FIH has also been implicated in cancer and heart disease. We have recently found evidence suggesting that FIH can also influence the activity of the Notch proteins. This means that oxygen levels can potentially have an effect on stem cells and other processes controlled by Notch, and may be very important in cancer and other diseases. This project will first confirm the connection between FIH and Notch. There are a number of different Notch proteins, so we will see if this connection works with all of them. It will also try and work out the consequence of this connection is and how important it is. Finally, the likely biological consequences on human diseases, specifically cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Novel Photoreceptor Bioenergetics: Basic Science and Clinical Translation
-
批准号:nhmrc : 1099932
-
项目类别:Project Grants
-
资助金额:$48.25万
-
财政年份:2016
-
负责人:A/Pr Daniel Peet
-
依托单位:
Novel Photoreceptor Bioenergetics: Basic Science and Clinical Translation
-
批准号:nhmrc : GNT1099932
-
项目类别:Project Grants
-
资助金额:$70.11万
-
财政年份:2016
-
负责人:A/Pr Daniel Peet
-
依托单位:
Deciphering specific roles for the common Arnt proteins in bHLH/PAS transcription factor complexes
-
批准号:nhmrc : 1070909
-
项目类别:Project Grants
-
资助金额:$35.1万
-
财政年份:2014
-
负责人:A/Pr Daniel Peet
-
依托单位:
Functions of Arnt1 and Arnt2
-
批准号:nhmrc : GNT1070909
-
项目类别:Project Grants
-
资助金额:$33.95万
-
财政年份:2014
-
负责人:A/Pr Daniel Peet
-
依托单位:
Is Hypoxia Inducible Factor 2 the Trigger of the Angiogenic Switch and a Driver of Disease Progression in Myeloma?
-
批准号:nhmrc : 626911
-
项目类别:NHMRC Project Grants
-
资助金额:$40.35万
-
财政年份:2010
-
负责人:A/Pr Daniel Peet
-
依托单位:
The Role of CXCL12 (SDF-1)/CXCR4 in Pathological Angiogenesis and Osteolytic Bone Disease in Multiple Myeloma
-
批准号:nhmrc : 453495
-
项目类别:NHMRC Project Grants
-
资助金额:$44.4万
-
财政年份:2007
-
负责人:A/Pr Daniel Peet
-
依托单位:
Identification and characterisation of novel hydroxylases and their substrates involved in cellular hypoxic response.
-
批准号:nhmrc : 299054
-
项目类别:NHMRC Project Grants
-
资助金额:$15.95万
-
财政年份:2004
-
负责人:A/Pr Daniel Peet
-
依托单位:
Activation mechanisms of the Hypoxia Inducible Factor-1a (HIF-1a) and the HIF-Like-Factor
-
批准号:nhmrc : 207820
-
项目类别:NHMRC Project Grants
-
资助金额:$21.11万
-
财政年份:2002
-
负责人:A/Pr Daniel Peet
-
依托单位:
Roles of Chaperone Proteins and Phosphorylation Events in activity of the Dioxin Receptor
-
批准号:nhmrc : 157966
-
项目类别:NHMRC Project Grants
-
资助金额:$15.14万
-
财政年份:2001
-
负责人:A/Pr Daniel Peet
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于 ANKRD22 介导的脂代谢重编程激活Notch4/HES1 通路促进巨噬细胞获得免疫抑制表型机制研究
-
批准号:ZCLMS26H1601
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖于飞
-
依托单位:
电针调控 Notch 信号通路促进脑缺血再灌注损伤神经血管单元调节和保护作用
-
批准号:2026JJ82306
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:袁高明
-
依托单位:
MPE细胞团中α-SMA+肿瘤细胞激活Notch 通路促恶性进展的作用机制研究
-
批准号:JCZRQNB202600536
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
小白菊内酯衍生物ACT001通过下调Notch1-Itgb1信号通路开放胶质瘤血肿瘤屏障促进替莫唑胺渗透入脑的作用与机制研究
-
批准号:JCZRLH202601645
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
超级增强子NFIX-SE募集MEF2C激活NFIX/NOTCH通路增强肿瘤细胞干性导致小细胞肺癌化疗耐药的机制研究
-
批准号:2026JJ81772
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:童琴
-
依托单位:
肝巨噬细胞Notch1信号调控肝细胞铁死亡促进NASH进展的机制研究
-
批准号:JCZRQNB202600718
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
PUM3通过稳定COL10A1表达调节TGF-β/c-MYC和Notch1通路促进前列腺癌骨转移进程的机制研究
-
批准号:JCZRLH202600428
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
NOTCH基因突变通过胸腺细胞选择相关HMG盒蛋白TOX调控的非小细胞肺癌T细胞耗竭的机制研究
-
批准号:JCZRLH202600761
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
双歧杆菌与消退素RvD1协同调控IL-6/STAT3/Notch信号轴介导结肠癌EMT及免疫调节的机制研究
-
批准号:JCZRLH202601410
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
动脉粥样硬化进程中VSMC表型转化调控新机制:TRIM65抑制Notch信号介导血管平滑肌细胞巨噬样转变
-
批准号:2026JJ80161
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:周支香
-
依托单位: